Induction chemotherapy followed by adjuvant surgery (IC-AS) in patients with stage I-II small cell lung cancer (SCLC)

T. Shibayama, J. Hiyama, H. Ueoka, M. Tabata, Y. Segawa, K. Gemba, A. Matsushita, T. Ohnoshi, M. Harada, A. Andoh, N. Shimizu, S. Hiraki

Research output: Contribution to journalArticlepeer-review

Abstract

Ten patients with stage I-II SCLC received IC-AS between 1984 and 1993. As induction chemotherapy, COMP-VAN alternating chemotherapy and CAV-PVP hybrid chemotherapy were administered. The former consisted of a 4 drug combination of cyclophosphamide(CPA), vincristine(VCR), methotrexate (MTX) and procarbazine alternated with a 3-drug combination of etoposide (ETP), adriamycin (ADM) and nimustine every 4 weeks. In the latter, a 3 drug combination of CPA, ADM and VCR given on day 1, and a 2 drug combination of ETP and cisplatin on day 8, were repeated every 4 weeks. All the patients had an objective response, including one complete response by induction chemotherapy. Post-operative pathology revealed SCLC in 4 patients, adenocarcinoma in 2 and no tumor (pathological CR) in 4. Four patients relapsed, and a intrathoracic relapse was experienced in only 2 patients. Six patients have died: 3 from relapsing SCLC, 2 from stomach cancer, and 1 from squamous lung cancer, who was salvaged from relapsing SCLC. The median survival time was 27.5 months, and the 3-year survival rate 37.5%. These results indicate that IC-AS is highly effective for stage I-II SCLC and warrant additional studies comparing IC-AS with chemo-radiotherapy.

Original languageEnglish
Pages (from-to)1953-1958
Number of pages6
JournalJapanese Journal of Cancer and Chemotherapy
Volume22
Issue number13
Publication statusPublished - 1995

Keywords

  • Chemotherapy
  • Small cell lung cancer
  • Surgery

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Fingerprint Dive into the research topics of 'Induction chemotherapy followed by adjuvant surgery (IC-AS) in patients with stage I-II small cell lung cancer (SCLC)'. Together they form a unique fingerprint.

Cite this